Clinical Benefit
| Moderate |
Le service médical rendu par cette spécialité est modéré dans l’hypertrophie bénigne de la prostate non compliquée.
|
Clinical Added Value
| no clinical added value |
OMEXEL LP 0,4mg (gel matriciel) n’apporte pas d’amélioration du service.
|
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
rDdj3QGRsdVvdJtB